BN 52211: a newly synthesized aza alkyl lysophosplipid of MW 536; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 131968 |
CHEMBL ID | 2001852 |
SCHEMBL ID | 9614165 |
MeSH ID | M0196439 |
Synonym |
---|
3,5-dioxa-9-aza-4-phosphaheptacosan-1-aminium, 4-hydroxy-7-methoxy-n,n,n,9-tetramethyl-, hydroxide, inner salt, 4-oxide |
bn 52211 |
nsc-643828 |
9-aza-3, 4-hydroxy- 7-methoxy-9,n,n,n-tetramethyl-, inner salt,4-oxide |
choline, 2-methoxy- 3-[methyl(octadecyl)amino]propyl hydrogen phosphate, inner salt |
nsc643828 |
136533-74-9 |
CHEMBL2001852 |
SCHEMBL9614165 |
DTXSID90929458 |
2-methoxy-3-[methyl(octadecyl)amino]propyl 2-(trimethylazaniumyl)ethyl phosphate |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.66) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |